keyword
MENU ▼
Read by QxMD icon Read
search

indication and contra indications of drugs

keyword
https://www.readbyqxmd.com/read/27890312/variables-associated-with-loss-of-ileoanal-pouches-constructed-in-childhood
#1
Khaled Abdelaal, Bruce Jaffray
AIMS: To quantify the incidence of loss of an ileoanal pouch in children and to identify variables associated this event. METHODS: Logistic regression of possible explanatory variables: age, sex, indication for procto-colectomy, pre-operative continence status, use of immunosuppressive drugs, open or laparoscopic surgery, number of stages, anastomotic leak, operative complication excluding anastomotic leak, performance of revisional surgery, albumin concentration and platelet count at time of surgery, rank order in series...
November 13, 2016: Journal of Pediatric Surgery
https://www.readbyqxmd.com/read/27846898/antibiotics-in-malaria-therapy-which-antibiotics-except-tetracyclines-and-macrolides-may-be-used-against-malaria
#2
REVIEW
Tiphaine Gaillard, Marylin Madamet, Francis Foguim Tsombeng, Jérôme Dormoi, Bruno Pradines
Malaria, a parasite vector-borne disease, is one of the most significant health threats in tropical regions, despite the availability of individual chemoprophylaxis. Malaria chemoprophylaxis and chemotherapy remain a major area of research, and new drug molecules are constantly being developed before drug-resistant parasites strains emerge. The use of anti-malarial drugs is challenged by contra-indications, the level of resistance of Plasmodium falciparum in endemic areas, clinical tolerance and financial cost...
November 15, 2016: Malaria Journal
https://www.readbyqxmd.com/read/27692384/-compliance-and-leaflet-s-reading-which-link-and-which-media-results-from-a-french-population-with-chronic-kidney-disease
#3
Clotilde Muller, Dorothée Bazin Kara, Marion Fourtage, Julien Ott, Thierry Krummel, Olivier Imhoff, Antoine Garstka, Sarah Richter, Isabelle Kolb, Anne-Laure Faller, Philippe Petit-Jean, Clotilde Kiener, Farideh Alenabi, Henriette Sissoko, Émilie Léon, François Chantrel, Yves Dimitrov, Thierry Hannedouche
Leaflets inside drug boxes are complex and often poorly understood. Patients consulting in nephrology are mostly old and often suffer from multiple comorbidities. As so, they are often subject to various contra-indications and drug interactions. This paper aims to evaluate if patients actually read leaflets or other medical information on others medias such as Internet and whether this could, potentially, interfere with their observance. Results showed that leaflets were read by 65.1% of patients, leading to 12% of withdrawal or not taking drugs...
September 27, 2016: Néphrologie & Thérapeutique
https://www.readbyqxmd.com/read/27639946/-sub-maximal-aerobic-capacity-and-quality-of-life-of-patients-with-rheumatoid-arthritis
#4
S Lataoui, S Belghali, H Zeglaoui, E Bouajina, H Ben Saad
BACKGROUND: Studies about sub-maximal aerobic capacity of patients with rheumatoid arthritis are scarce. AIMS: To assess the sub-maximal aerobic capacity of these patients through the 6-min walk test, estimated age of the "muscular and cardiorespiratory" chain. METHODS: Thirty-seven consecutive patients (aged 20 to 60 years) with newly diagnosed rheumatoid arthritis will be included. Non-inclusion criteria will be: use of drugs (e.g.; methotrexate, beta-blockers), orthopaedic or rheumatologic conditions (other than rheumatoid arthritis) that may alter walking ability and recent infections...
September 14, 2016: Revue des Maladies Respiratoires
https://www.readbyqxmd.com/read/27522186/-recommendations-in-case-of-radiation-of-patient-with-a-pacemaker-or-an-implantable-defibrillator
#5
I Barillot, R Mazeron, F Mornex, P Giraud
Patients with pacemakers or defibrillators have a relative contra-indication for radiotherapy. This review presents the precautions issued by the French agency for drug safety (ANSM).
September 2016: Cancer Radiothérapie: Journal de la Société Française de Radiothérapie Oncologique
https://www.readbyqxmd.com/read/27329436/considerations-challenges-and-future-of-anti-tnf-therapy-in-treating-inflammatory-bowel-disease
#6
Lieven Pouillon, Peter Bossuyt, Laurent Peyrin-Biroulet
INTRODUCTION: Crohn's disease (CD) and ulcerative colitis (UC) are chronic disabling conditions. Monoclonal antibody therapy directed against tumor necrosis factor-alpha (anti-TNF) has revolutionized the care of patients with inflammatory bowel disease (IBD). AREAS COVERED: Considerations before starting anti-TNF therapy are highlighted: the best time to start with anti-TNF therapy, either alone or in combination with an immunomodulator, the choice of an anti-TNF agent and the contra-indications to anti-TNF therapy...
October 2016: Expert Opinion on Biological Therapy
https://www.readbyqxmd.com/read/27151405/druggenex-net-a-novel-computational-platform-for-systems-pharmacology-and-gene-expression-based-drug-repurposing
#7
Naiem T Issa, Jordan Kruger, Henri Wathieu, Rajarajan Raja, Stephen W Byers, Sivanesan Dakshanamurthy
BACKGROUND: The targeting of disease-related proteins is important for drug discovery, and yet target-based discovery has not been fruitful. Contextualizing overall biological processes is critical to formulating successful drug-disease hypotheses. Network pharmacology helps to overcome target-based bottlenecks through systems biology analytics, such as protein-protein interaction (PPI) networks and pathway regulation. RESULTS: We present a systems polypharmacology platform entitled DrugGenEx-Net (DGE-NET)...
2016: BMC Bioinformatics
https://www.readbyqxmd.com/read/27085011/peripheral-vasoconstriction-induced-by-%C3%AE-adrenoceptor-blockers-a-systematic-review-and-a-network-meta-analysis
#8
REVIEW
Charles Khouri, Thomas Jouve, Sophie Blaise, Patrick Carpentier, Jean-Luc Cracowski, Matthieu Roustit
AIM: Peripheral vasoconstriction has long been described as a vascular adverse effect of β-adrenoceptor blockers. Whether β-adrenoceptor blockers should be avoided in patients with peripheral vascular disease depends on pharmacological properties (e.g. preferential binding to β1 -adrenoreceptors or intrinsic sympathomimetic activity). However, this has not been confirmed in experimental studies. We performed a network meta-analysis in order to assess the comparative risk of peripheral vasoconstriction of different β-adrenoceptor blockers...
August 2016: British Journal of Clinical Pharmacology
https://www.readbyqxmd.com/read/27017899/17d-yellow-fever-vaccine-elicits-comparable-long-term-immune-responses-in-healthy-individuals-and-immune-compromised-patients
#9
R W Wieten, A Goorhuis, E F F Jonker, G J de Bree, A W de Visser, P J J van Genderen, E B M Remmerswaal, I J M Ten Berge, L G Visser, M P Grobusch, E M M van Leeuwen
BACKGROUND: The 17D live attenuated yellow fever (YF) vaccine is contra-indicated in immune-compromised individuals and may elicit a suboptimal immunologic response. The aim of this study is to assess whether long-term immune responses against the YF vaccine are impaired in immune-compromised patients. MATERIALS AND METHODS: Fifteen patients using different immunosuppressive drugs and 30 healthy individuals vaccinated 0-22 years ago were included. The serological response was measured using the plaque reduction neutralization test (PRNT)...
June 2016: Journal of Infection
https://www.readbyqxmd.com/read/26946710/-pharmacovigilance-update
#10
Kim Dao, Haithem Chtioui, Laura E Rothuizen, Léonore Diezi, Sylvain Prod'hom, Ursula Winterfeld, Thierry Buclin, Françoise Livio
The main pharmacovigilance updates in 2015are reviewed. Sofosbuvir amiodarone interaction: risk of severe bradycardia. Dasabuvir clopidogrel interaction: increased dasabuvir concentrations and potential risk of QTprolongation. SGLT2 inhibitors: risks of diabetic acidocetosis and bone fracture. Dabigatran: therapeutic drug monitoring may improve benefit-risk ratio. Ibuprofen: at higher dosage, vascular risks are comparable to coxibs. Pregabaline, gabapentine: potential for abuse and addiction. Varenicline: potentiates alcohol's effects...
January 13, 2016: Revue Médicale Suisse
https://www.readbyqxmd.com/read/26932124/the-missing-cause-approach-to-unmeasured-confounding-in-pharmacoepidemiology
#11
Michal Abrahamowicz, Lise M Bjerre, Marie-Eve Beauchamp, Jacques LeLorier, Rebecca Burne
Unmeasured confounding is a major threat to the validity of pharmacoepidemiological studies of medication safety and effectiveness. We propose a new method for detecting and reducing the impact of unobserved confounding in large observational database studies. The method uses assumptions similar to the prescribing preference-based instrumental variable (IV) approach. Our method relies on the new 'missing cause' principle, according to which the impact of unmeasured confounding by (contra-)indication may be detected by assessing discrepancies between the following: (i) treatment actually received by individual patients and (ii) treatment that they would be expected to receive based on the observed data...
March 30, 2016: Statistics in Medicine
https://www.readbyqxmd.com/read/26885653/-drug-coated-balloons-in-the-treatment-of-peripheral-artery-disease-pad-history-and-current-level-of-evidence
#12
M Herten, S Stahlhoff, B Imm, E Schönefeld, A Schwindt, G B Torsello
BACKGROUND: Despite initially encouraging technical success after femoropopliteal PTA, restenosis remains the major challenge in patients with peripheral artery disease (PAD). The main cause of restenosis is neointimal hyperplasia which can be suppressed by antiproliferative drugs. Drug-coated balloons (DCB) or drug-eluting stents (DES) are used for the inhibition of restenosis. OBJECTIVES: The present article gives an overview of DCB development, actual DCB systems for femoro- and infrapopliteal use, displays the outcomes of randomized clinical trials and the discusses the evidence for the DCB treatment in PAD...
March 2016: Der Radiologe
https://www.readbyqxmd.com/read/26547678/treatment-of-pulmonary-embolism
#13
REVIEW
Hervé Décousus, Patrick Mismetti, Francis Couturaud, Walter Ageno, Rupert Bauersachs
The treatment of pulmonary embolism is going to be deeply modified by the development of Direct Oral Anticoagulants (DOACs). There are currently three anti-Xa factors (rivaroxaban, apixaban, edoxaban) and one anti-IIa factor (dabigatran) labeled by the FDA and the EMA. All these drugs are direct anticoagulant, orally effective, without the need for adaptation to hemostasis test. As kidney excretion is involved for all of them, they are contra-indicated in patients with severe renal failure (creatinine clearance < 30 mL/min according to Cockcroft & Gault formula)...
December 2015: La Presse Médicale
https://www.readbyqxmd.com/read/26537779/evaluation-of-nd-yag-laser-device-efficacy-on-onychomycosis-a-case-series-of-30-patients
#14
J Helou, I Maatouk, M A Hajjar, R Moutran
Until recently, pharmacologic molecules have been the only available treatments for onychomycosis. Laser treatments were introduced for recurrent or resistant cases or in patients in whom oral treatments are contra-indicated. Some devices were approved by the Food and Drug Administration (FDA). Neodymium yttrium aluminium garnet (Nd:YAG) is used for onychomycosis as a short-pulse or a long-pulse system. We aim to evaluate the efficacy of the short-pulse Nd:YAG in treating onychomycosis, its side effects, cure rates, and 12-month recurrence rates...
January 2016: Mycoses
https://www.readbyqxmd.com/read/26466809/alternative-forms-of-hydration-in-patients-with-cancer-in-the-last-days-of-life-study-protocol-for-a-randomised-controlled-trial
#15
RANDOMIZED CONTROLLED TRIAL
Andrew Davies, Melanie Waghorn, Julia Boyle, Ann Gallagher, Sigurd Johnsen
BACKGROUND: The provision of clinically assisted hydration at the end of life is one of the most contentious issues in medicine, and indeed within the general population. The reasons for contention include: a) the lack of evidence for or against; b) the disparate opinions of healthcare professionals; and c) the generally positive opinions of patients and their carers about clinically assisted hydration. METHODS/DESIGN: The study is a cluster randomised trial to assess the feasibility of conducting an adequately powered, randomised controlled trial of clinically assisted hydration in patients with cancer in the last days of life...
October 14, 2015: Trials
https://www.readbyqxmd.com/read/26389028/vismodegib-hedgehog-signaling-inhibition-and-treatment-of-basal-cell-carcinomas-as-well-as-keratocystic-odontogenic-tumors-in-gorlin-syndrome
#16
REVIEW
Patrick Booms, Marc Harth, Robert Sader, Shahram Ghanaati
Vismodegib hedgehog signaling inhibition treatment has potential for reducing the burden of multiple skin basal cell carcinomas and jaw keratocystic odontogenic tumors. They are major criteria for the diagnosis of Gorlin syndrome, also called nevoid basal cell carcinoma syndrome. Clinical features of Gorlin syndrome are reported, and the relevance of hedgehog signaling pathway inhibition by oral vismodegib for maxillofacial surgeons is highlighted. In summary, progressed basal cell carcinoma lesions are virtually inoperable...
January 2015: Annals of Maxillofacial Surgery
https://www.readbyqxmd.com/read/26350554/-perstimulus-asystole-during-electroconvulsive-therapy-clinical-case-and-critical-literature-review
#17
N C Roche, L Raynaud, F Bompaire, J-J Lucas, Y Auxéméry
INTRODUCTION: Electroconvulsive therapy (ECT) is most frequently indicated for episodes of melancholic depression, but is also useful in the treatment of maniac syndrome and some schizophrenia subtypes. ECT is part of the treatment of movement disorders, neuroleptic malignant syndrome and even in the treatment of severe conversions. Although the therapeutic results are excellent when used appropriately, the mortality rate is estimated between 2 and 4 for 100,000 shocks. Despite this mortality rate, the benefit-risk ratio remains very positive and serious complications are extremely rare...
February 2016: L'Encéphale
https://www.readbyqxmd.com/read/26324153/if-not-now-when-prescription-of-evidence-based-medical-therapy-prior-to-hospital-discharge-increases-utilization-at-6-months-in-patients-with-symptomatic-peripheral-artery-disease
#18
MULTICENTER STUDY
Brian M Renard, Milan Seth, David Share, Herb D Aronow, Eugene W Laveroni, Michele De Gregorio, Sachinder S Hans, Peter K Henke, Hitinder S Gurm, P Michael Grossman
We evaluated the impact of the prescription of evidence-based medical therapy (EBMT) including aspirin (ASA), beta-blockers (BB), ACE-inhibitors or angiotensin receptor blockade (ACE/ARB), and statins prior to discharge after peripheral vascular intervention (PVI) on long-term medication utilization in a large multi-specialty, multicenter quality improvement collaborative. Among patients undergoing coronary revascularization, use of the component medications of EBMT at hospital discharge is a major predictor of long-term utilization...
December 2015: Vascular Medicine
https://www.readbyqxmd.com/read/26250892/prednisolone-does-not-affect-direct-acting-antivirals-against-hepatitis-c-but-inhibits-interferon-alpha-production-by-plasmacytoid-dendritic-cells
#19
P E de Ruiter, P P C Boor, J de Jonge, H J Metselaar, H W Tilanus, J N Ijzermans, J Kwekkeboom, L J W van der Laan
BACKGROUND: Chronic hepatitis C virus (HCV) infection compromises long-term outcomes of liver transplantation. Although glucocorticosteroid-based immunosuppression is commonly used, discussion is ongoing on the effect of prednisolone (Pred) on HCV recurrence and response to antiviral therapy post transplantation. Recently, new drugs (direct-acting antivirals) have been approved for the treatment of HCV, however, it remains unknown whether their antiviral activity is affected by Pred. The aim of this study was to investigate the effects of Pred on the antiviral activity of asunaprevir (Asu), daclatasvir (Dac), ribavirin (RBV), and interferon-alpha (IFN-α), and on plasmacytoid dendritic cells (PDCs), the main IFN-α-producing immune cells...
October 2015: Transplant Infectious Disease: An Official Journal of the Transplantation Society
https://www.readbyqxmd.com/read/26119971/primary-percutaneous-coronary-intervention-by-drug-eluting-balloon-angioplasty-the-nonrandomized-fourth-arm-of-the-deb-ami-drug-eluting-balloon-in-st-segment-elevation-myocardial-infarction-trial
#20
Freek Nijhoff, Pierfrancesco Agostoni, Anouar Belkacemi, Hendrik M Nathoe, Michiel Voskuil, Mariam Samim, Pieter A Doevendans, Pieter R Stella
OBJECTIVE: To evaluate a paclitaxel drug-eluting balloon (DEB) only strategy in primary percutaneous coronary intervention (PPCI), aiming at a comparison with bare metal stent (BMS) alone, DEB followed by BMS, and paclitaxel eluting stent (PES), as assessed in the randomized Drug Eluting Balloon in Acute ST-Segment Elevation Myocardial Infarction (DEB-AMI) trial. BACKGROUND: DEB-only seems an attractive strategy in PPCI, as it obviates the risk of stent thrombosis...
October 2015: Catheterization and Cardiovascular Interventions
keyword
keyword
49045
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"